Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. - Apostolidou E; Kantarjian H; Thomas D; Burger I; Borthakur G; Verstovsek S (Clinical lymphoma, myeloma & leukemia, 2010)